Sucampo Pharmaceuticals Stock Price To Earning
Sucampo Pharmaceuticals fundamentals help investors to digest information that contributes to Sucampo Pharmaceuticals' financial success or failures. It also enables traders to predict the movement of Sucampo Stock. The fundamental analysis module provides a way to measure Sucampo Pharmaceuticals' intrinsic value by examining its available economic and financial indicators, including the cash flow records, the balance sheet account changes, the income statement patterns, and various microeconomic indicators and financial ratios related to Sucampo Pharmaceuticals stock.
Sucampo |
Sucampo Pharmaceuticals Company Price To Earning Analysis
Sucampo Pharmaceuticals' Price to Earnings ratio is typically used for current valuation of a company and is one of the most popular ratios that investors monitor daily. Holding a low PE stock is less risky because when a company's profitability falls, it is likely that earnings will also go down as well. In other words, if you start from a lower position, your downside risk is limited. There are also some investors who believe that low Price to Earnings ratio reflects the low pricing because a given company is in trouble. On the other hand, a higher PE ratio means that investors are paying more for each unit of profit.
Current Sucampo Pharmaceuticals Price To Earning | (2.77) X |
Most of Sucampo Pharmaceuticals' fundamental indicators, such as Price To Earning, are part of a valuation analysis module that helps investors searching for stocks that are currently trading at higher or lower prices than their real value. If the real value is higher than the market price, Sucampo Pharmaceuticals is considered to be undervalued, and we provide a buy recommendation. Otherwise, we render a sell signal.
Generally speaking, the Price to Earnings ratio gives investors an idea of what the market is willing to pay for the company's current earnings.
CompetitionBased on the latest financial disclosure, Sucampo Pharmaceuticals has a Price To Earning of -2.77 times. This is 110.72% lower than that of the sector and 106.78% lower than that of the Price To Earning industry. The price to earning for all United States stocks is 109.64% higher than that of the company.
Sucampo Price To Earning Peer Comparison
Stock peer comparison is one of the most widely used and accepted methods of equity analyses. It analyses Sucampo Pharmaceuticals' direct or indirect competition against its Price To Earning to detect undervalued stocks with similar characteristics or determine the stocks which would be a good addition to a portfolio. Peer analysis of Sucampo Pharmaceuticals could also be used in its relative valuation, which is a method of valuing Sucampo Pharmaceuticals by comparing valuation metrics of similar companies.Sucampo Pharmaceuticals is currently under evaluation in price to earning category among related companies.
Sucampo Fundamentals
| Return On Equity | 14.16 | |||
| Return On Asset | 0.0296 | |||
| Profit Margin | 7.80 % | |||
| Operating Margin | 30.77 % | |||
| Current Valuation | 1.05 B | |||
| Shares Outstanding | 47.09 M | |||
| Shares Owned By Insiders | 35.13 % | |||
| Shares Owned By Institutions | 82.48 % | |||
| Number Of Shares Shorted | 4.59 M | |||
| Price To Earning | (2.77) X | |||
| Price To Book | 21.08 X | |||
| Price To Sales | 3.38 X | |||
| Revenue | 250.47 M | |||
| Gross Profit | 154.05 M | |||
| EBITDA | 107.24 M | |||
| Net Income | (150.89 M) | |||
| Cash And Equivalents | 75.04 M | |||
| Cash Per Share | 1.62 X | |||
| Total Debt | 293.54 M | |||
| Debt To Equity | 740.60 % | |||
| Current Ratio | 5.11 X | |||
| Book Value Per Share | 2.26 X | |||
| Cash Flow From Operations | 28.51 M | |||
| Short Ratio | 9.78 X | |||
| Earnings Per Share | (3.37) X | |||
| Price To Earnings To Growth | 5.30 X | |||
| Number Of Employees | 139 | |||
| Beta | 0.58 | |||
| Market Capitalization | 847.54 M | |||
| Total Asset | 457.18 M | |||
| Retained Earnings | 24.37 M | |||
| Working Capital | 163.23 M | |||
| Current Asset | 251.36 M | |||
| Current Liabilities | 88.13 M | |||
| Z Score | 1.2 |
Currently Active Assets on Macroaxis
Check out World Market Map to better understand how to build diversified portfolios. Also, note that the market value of any company could be tightly coupled with the direction of predictive economic indicators such as signals in population. You can also try the Alpha Finder module to use alpha and beta coefficients to find investment opportunities after accounting for the risk.
Other Consideration for investing in Sucampo Stock
If you are still planning to invest in Sucampo Pharmaceuticals check if it may still be traded through OTC markets such as Pink Sheets or OTC Bulletin Board. You may also purchase it directly from the company, but this is not always possible and may require contacting the company directly. Please note that delisted stocks are often considered to be more risky investments, as they are no longer subject to the same regulatory and reporting requirements as listed stocks. Therefore, it is essential to carefully research the Sucampo Pharmaceuticals' history and understand the potential risks before investing.
| Portfolio Diagnostics Use generated alerts and portfolio events aggregator to diagnose current holdings | |
| Instant Ratings Determine any equity ratings based on digital recommendations. Macroaxis instant equity ratings are based on combination of fundamental analysis and risk-adjusted market performance | |
| Fundamental Analysis View fundamental data based on most recent published financial statements | |
| Top Crypto Exchanges Search and analyze digital assets across top global cryptocurrency exchanges | |
| Portfolio Manager State of the art Portfolio Manager to monitor and improve performance of your invested capital | |
| Portfolio Anywhere Track or share privately all of your investments from the convenience of any device | |
| Global Markets Map Get a quick overview of global market snapshot using zoomable world map. Drill down to check world indexes | |
| Headlines Timeline Stay connected to all market stories and filter out noise. Drill down to analyze hype elasticity | |
| Portfolio Optimization Compute new portfolio that will generate highest expected return given your specified tolerance for risk | |
| Alpha Finder Use alpha and beta coefficients to find investment opportunities after accounting for the risk | |
| Idea Breakdown Analyze constituents of all Macroaxis ideas. Macroaxis investment ideas are predefined, sector-focused investing themes | |
| Idea Analyzer Analyze all characteristics, volatility and risk-adjusted return of Macroaxis ideas | |
| Portfolio Suggestion Get suggestions outside of your existing asset allocation including your own model portfolios |